Yan‐Xing Chen
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 6
- Cancer Genomics and Diagnostics 4
- Cancer, Hypoxia, and Metabolism 2
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 2
- Co-authors
- Rui‐Hua Xu (20 shared papers)Qi Zhao (9 shared papers)Zhao-Lei Zeng (11 shared papers)Huai‐Qiang Ju (10 shared papers)Zexian Liu (13 shared papers)Hao‐Xiang Wu (6 shared papers)De‐Shen Wang (5 shared papers)Zixian Wang (7 shared papers)
- Journals
- Nature Communications (3 papers)Journal of Clinical Oncology (2 papers)Gut (2 papers)Signal Transduction and Targeted Therapy (1 paper)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Yan‐Xing Chen
24 papers receiving 1.3k citations
Yan‐Xing Chen's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 602
- Oncology 273
- Molecular Biology 700
- Immunology 149
- Pulmonary and Respiratory Medicine 147
Countries citing papers authored by Yan‐Xing Chen
This map shows the geographic impact of Yan‐Xing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Xing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Xing Chen more than expected).
Fields of papers citing papers by Yan‐Xing Chen
This network shows the impact of papers produced by Yan‐Xing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Xing Chen. The network helps show where Yan‐Xing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan‐Xing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer Hit paper breakdown → | 2019 | 381 |
| 2 | Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response Hit paper breakdown → | 2022 | 180 |
| 3 | 2022 | 146 | |
| 4 | 2020 | 85 | |
| 5 | 2019 | 69 | |
| 6 | 2020 | 48 | |
| 7 | 2023 | 48 | |
| 8 | 2022 | 40 | |
| 9 | 2021 | 33 | |
| 10 | 2023 | 31 | |
| 11 | 2021 | 30 | |
| 12 | 2021 | 30 | |
| 13 | 2023 | 25 | |
| 14 | 2022 | 24 | |
| 15 | 2021 | 24 | |
| 16 | 2022 | 22 | |
| 17 | 2024 | 18 | |
| 18 | 2015 | 18 | |
| 19 | 2023 | 15 | |
| 20 | 2024 | 5 |
About Yan‐Xing Chen
Yan‐Xing Chen is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Surgery, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), RNA modifications and cancer (4 papers), Immune cells in cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Cancer Research (602 citations), Oncology (273 citations), Molecular Biology (700 citations), Immunology (149 citations) and Pulmonary and Respiratory Medicine (147 citations). Yan‐Xing Chen has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Rui‐Hua Xu, Qi Zhao, Zhao-Lei Zeng, Huai‐Qiang Ju, Zexian Liu, Hao‐Xiang Wu, De‐Shen Wang, Zixian Wang, Ying-Nan Wang and Hui Luo. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology, Gut, Signal Transduction and Targeted Therapy and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.